rs191989562

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_002458.3(MUC5B):​c.14584G>A​(p.Gly4862Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000188 in 1,544,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G4862D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.656

Publications

4 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056443214).
BP6
Variant 11-1251464-G-A is Benign according to our data. Variant chr11-1251464-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 403196.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.14584G>A p.Gly4862Ser missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.14584G>A p.Gly4862Ser missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84

Frequencies

GnomAD3 genomes
AF:
0.000660
AC:
95
AN:
143874
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000200
Gnomad ASJ
AF:
0.000306
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00229
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000788
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00150
AC:
356
AN:
237108
AF XY:
0.00134
show subpopulations
Gnomad AFR exome
AF:
0.000333
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.0137
Gnomad NFE exome
AF:
0.000758
Gnomad OTH exome
AF:
0.000869
GnomAD4 exome
AF:
0.000139
AC:
195
AN:
1400966
Hom.:
0
Cov.:
96
AF XY:
0.000130
AC XY:
91
AN XY:
697968
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000606
AC:
2
AN:
32990
American (AMR)
AF:
0.00
AC:
0
AN:
44312
Ashkenazi Jewish (ASJ)
AF:
0.0000395
AC:
1
AN:
25316
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000351
AC:
3
AN:
85420
European-Finnish (FIN)
AF:
0.00181
AC:
90
AN:
49624
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5728
European-Non Finnish (NFE)
AF:
0.0000897
AC:
95
AN:
1059538
Other (OTH)
AF:
0.0000514
AC:
3
AN:
58342
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.302
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000660
AC:
95
AN:
143874
Hom.:
0
Cov.:
32
AF XY:
0.000741
AC XY:
52
AN XY:
70184
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000500
AC:
20
AN:
40040
American (AMR)
AF:
0.000200
AC:
3
AN:
14986
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
1
AN:
3268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5100
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4656
European-Finnish (FIN)
AF:
0.00229
AC:
21
AN:
9166
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000788
AC:
50
AN:
63456
Other (OTH)
AF:
0.00
AC:
0
AN:
1990
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.368
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
0
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.0218
AC:
84
ExAC
AF:
0.00177
AC:
215

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.54
DANN
Benign
0.49
DEOGEN2
Benign
0.020
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0081
N
LIST_S2
Benign
0.43
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
M
PhyloP100
-0.66
PrimateAI
Benign
0.18
T
PROVEAN
Benign
-0.61
N
REVEL
Benign
0.078
Sift
Benign
0.40
T
Vest4
0.060
MVP
0.11
ClinPred
0.0067
T
GERP RS
-3.8
Varity_R
0.031
gMVP
0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191989562; hg19: chr11-1272694; COSMIC: COSV71595233; COSMIC: COSV71595233; API